**Core Concept**
Bradykinin is a potent vasodilator and a key mediator in the inflammatory response. It is formed from the breakdown of kininogen by the action of kallikrein, an enzyme that plays a crucial role in the kinin-kallikrein system. Bradykinin exerts its effects by binding to its receptors on various cell types, leading to a cascade of physiological responses.

**Why the Correct Answer is Right**
Bradykinin causes pain at the site of inflammation by activating nociceptors, specialized sensory neurons that detect and transmit pain signals to the central nervous system. This occurs through the binding of bradykinin to its B2 receptors on nociceptors, which triggers an increase in the release of pain-producing chemicals such as substance P. The activation of nociceptors by bradykinin is a key mechanism by which inflammation leads to pain perception. Additionally, bradykinin also increases the permeability of blood vessels, leading to edema and further exacerbating pain.

**Why Each Wrong Option is Incorrect**
**Option A:** Vasoconstriction is actually caused by other mediators such as thromboxane A2 and endothelin-1, which are involved in the regulation of vascular tone. Bradykinin, on the other hand, is a potent vasodilator that causes blood vessels to dilate.

**Option C:** Bronchodilatation is primarily caused by the action of beta-2 adrenergic agonists, such as salbutamol, which are used to treat asthma and other respiratory conditions. Bradykinin does not have a significant effect on bronchial smooth muscle tone.

**Option D:** Decreased vascular permeability is actually caused by the action of vasoconstrictors, such as norepinephrine, which reduce blood flow to the affected area. Bradykinin, as mentioned earlier, increases vascular permeability, leading to edema and inflammation.

**Clinical Pearl / High-Yield Fact**
Bradykinin is a key mediator in the inflammatory response, and its effects are mediated by its binding to B1 and B2 receptors on various cell types. Understanding the role of bradykinin in inflammation is crucial for the diagnosis and management of conditions such as hereditary angioedema, which is caused by a deficiency in the C1 esterase inhibitor that regulates the kinin-kallikrein system.

✓ Correct Answer: B. Pain at the site of inflammation